Routine clinical evaluation of cerebrovascular reserve capacity using carbogen in patients with intracranial stenosis

Stroke

Volumn 45, Issue 8, 2014, Pages 2335-2341

  Donahue, Manus J ^a   Dethrage, Lindsey M ^a   Faraco, Carlos C ^a   Jordan, Lori C ^a   Clemmons, Paul ^a   Singer, Robert ^b   Mocco, J ^a   Shyr, Yu ^a   Desai, Aditi ^a   O'Duffy, Anne ^a   Riebau, Derek ^a   Hermann, Lisa ^a   Connors, John ^a   Kirshner, Howard ^a   Strother, Megan K ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

constriction, pathologic; hypercapnia; magnetic resonance imaging; regional blood flow; stroke

Indexed keywords

CONSTRICTION, PATHOLOGIC; HYPERCAPNIA; MAGNETIC RESONANCE IMAGING; REGIONAL BLOOD FLOW; STROKE;

ADULT; AGED; BRAIN; CARBON DIOXIDE; CEREBROVASCULAR CIRCULATION; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; MOYAMOYA DISEASE; OXYGEN;

EID: 84905390004     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005975     Document Type: Article

References (17)

1. Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013;12:1106-1114.
2. Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, et al; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014;383:333-341.
3. Zaidat OO, Castonguay AC, Fitzsimmons BF, Woodward BK, Wang Z, Killer-Oberpfalzer M, et al; VISSIT Trial Investigators. Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis. 2013;22:1131-1139.
4. Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology. 2006;66:1187-1191.
5. Liebeskind DS, Cotsonis GA, Saver JL, Lynn MJ, Turan TN, Cloft HJ, et al; Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Investigators. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011;69:963-974.
6. Derdeyn CP, Videen TO, Yundt KD, Fritsch SM, Carpenter DA, Grubb RL, et al. Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain. 2002;125(pt 3):595-607.
7. Donahue MJ, Strother MK, Hendrikse J. Novel MRI approaches for assessing cerebral hemodynamics in ischemic cerebrovascular disease. Stroke. 2012;43:903-915.
8. Wise RG, Pattinson KT, Bulte DP, Chiarelli PA, Mayhew SD, Balanos GM, et al. Dynamic forcing of end-tidal carbon dioxide and oxygen applied to functional magnetic resonance imaging. J Cereb Blood Flow Metab. 2007;27:1521-1532.
9. Yezhuvath US, Lewis-Amezcua K, Varghese R, Xiao G, Lu H. On the assessment of cerebrovascular reactivity using hypercapnia BOLD MRI. NMR Biomed. 2009;22:779-786.
10. Mandell DM, Han JS, Poublanc J, Crawley AP, Stainsby JA, Fisher JA, et al. Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in Patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI. Stroke. 2008;39:2021-2028.
11. Ashkanian M, Gjedde A, Mouridsen K, Vafaee M, Hansen KV, Ostergaard L, et al. Carbogen inhalation increases oxygen transport to hypoperfused brain tissue in patients with occlusive carotid artery disease: increased oxygen transport to hypoperfused brain. Brain Res. 2009;1304:90-95.
12. Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. FSL. Neuroimage. 2012;62:782-790.
13. Donahue MJ, Ayad M, Moore R, van Osch M, Singer R, Clemmons P, et al. Relationships between hypercarbic reactivity, cerebral blood flow, and arterial circulation times in patients with moyamoya disease. J Magn Reson Imaging. 2013;38:1129-1139.
14. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke. 1994;25:40-43.
15. Hare HV, Germuska M, Kelly ME, Bulte DP. Comparison of CO2 in air versus carbogen for the measurement of cerebrovascular reactivity with magnetic resonance imaging. J Cereb Blood Flow Metab. 2013;33:1799-1805.
16. Alsop DC, Detre JA, Golay X, Gunther M, Hendrikse J, Hernandez- Garcia L, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia [published online ahead of print date April 8, 2014]. Magn Reson Med. doi: 10.1002/mrm.25197. http://onlinelibrary.wiley.com/doi/10.1002/ mrm.25197/pdf. Accessed April 8, 2014.
17. Matteo Ciccone M, K Sharma R, Scicchitano P, Cortese F, Salerno C, Berchialla P, et al. Dolichocarotids: echo-color Doppler evaluation and clinical role. J Atheroscler Thromb. 2014;21:56-63.